HSICHENRY SCHEIN INC

Nasdaq henryschein.com


$ 72.79 $ -0.39 (-0.53 %)    

Thursday, 25-Apr-2024 15:59:55 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 72.82
$ 71.89
$ 0.00 x 0
$ 0.00 x 0
$ 71.89 - $ 73.15
$ 60.01 - $ 83.15
583,100
na
9.59B
$ 0.93
$ 23.06
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-30-2023 10-K
2 11-28-2023 09-30-2023 10-Q
3 08-07-2023 07-01-2023 10-Q
4 05-09-2023 04-01-2023 10-Q
5 02-21-2023 12-31-2022 10-K
6 11-01-2022 09-24-2022 10-Q
7 08-02-2022 06-25-2022 10-Q
8 05-03-2022 03-26-2022 10-Q
9 02-15-2022 12-25-2021 10-K
10 11-02-2021 09-25-2021 10-Q
11 08-03-2021 06-26-2021 10-Q
12 05-04-2021 03-27-2021 10-Q
13 02-17-2021 12-26-2020 10-K
14 11-02-2020 09-26-2020 10-Q
15 08-04-2020 06-27-2020 10-Q
16 05-05-2020 03-28-2020 10-Q
17 02-20-2020 12-28-2019 10-K
18 11-05-2019 09-28-2019 10-Q
19 08-06-2019 06-29-2019 10-Q
20 05-07-2019 03-30-2019 10-Q
21 02-20-2019 12-29-2018 10-K
22 11-06-2018 09-29-2018 10-Q
23 08-06-2018 08-06-2018 10-Q
24 05-08-2018 05-08-2018 10-Q
25 02-21-2018 02-21-2018 10-K
26 11-06-2017 11-06-2017 10-Q
27 08-08-2017 08-08-2017 10-Q
28 05-09-2017 05-09-2017 10-Q
29 02-21-2017 12-31-2016 10-K
30 11-02-2016 11-02-2016 10-Q
31 08-04-2016 08-04-2016 10-Q
32 05-03-2016 03-26-2016 10-Q
33 02-10-2016 12-26-2015 10-K
34 11-04-2015 09-26-2015 10-Q
35 07-29-2015 06-27-2015 10-Q
36 05-04-2015 03-28-2015 10-Q
37 02-11-2015 12-27-2014 10-K
38 11-06-2014 09-27-2014 10-Q
39 08-04-2014 06-28-2014 10-Q
40 05-06-2014 03-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jack-daniels-parent-company-ea-cognizant-among-6-stocks-that-shine-when-nvidia-slips-analysis

The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvi...

 jp-morgan-maintains-overweight-on-henry-schein-raises-price-target-to-88

JP Morgan analyst Rachel Vatnsdal maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $8...

 jefferies-maintains-hold-on-henry-schein-raises-price-target-to-81

Jefferies analyst Brandon Couillard maintains Henry Schein (NASDAQ:HSIC) with a Hold and raises the price target from $74 to...

 evercore-isi-group-maintains-in-line-on-henry-schein-raises-price-target-to-83

Evercore ISI Group analyst Ross Muken maintains Henry Schein (NASDAQ:HSIC) with a In-Line and raises the price target from $...

 barrington-research-maintains-outperform-on-henry-schein-raises-price-target-to-90

Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price targ...

 cybersecurity-incident-casts-shadow-on-henry-scheins-q4-performance-analysts-optimistic-on-dental-sector

Henry Schein reports fourth quarter 2023 sales at $3.02 billion. Despite cybersecurity challenges, William Blair is optimistic.

 henry-schein-q4-adjusted-eps-066-misses-070-estimate-sales-302b-miss-304b-estimate

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.70 ...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 henry-schein-earnings-preview
Henry Schein Earnings Preview
02/26/2024 15:02:11

 piper-sandler-maintains-overweight-on-henry-schein-raises-price-target-to-86

Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $...

 leerink-partners-initiates-coverage-on-henry-schein-with-market-perform-rating-announces-price-target-of-78

Leerink Partners analyst Michael Cherny initiates coverage on Henry Schein (NASDAQ:HSIC) with a Market Perform rating and an...

 henry-schein-has-agreed-to-acquire-a-majority-interest-in-trimed-a-developer-of-solutions-for-orthopedic-treatment-of-lower-extremities-foot-and-ankle-and-upper-extremities-primarily-hand-and-wrist-deal-terms-were-not-disclosed

TriMed had 2022 net sales of approximately $48 million. The transaction is subject to certain regulatory approvals and closing ...

 jp-morgan-upgrades-henry-schein-to-overweight-raises-price-target-to-82

JP Morgan analyst Rachel Vatnsdal upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Overweight and raises the price target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION